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Abstract
Background: Poor adherence is the main barrier to the effectiveness of HIV medication. The objective of this
study was to explore and conceptualize patterns and difficulties in physicians' work with patients' adherence to HIV
medication. No previous studies on this subject have directly observed physicians' behavior.
Methods: This is a qualitative, cross-sectional study. We used a Grounded Theory approach to let the main issues
in physicians' work with patients' adherence emerge without preconceiving the focus of the study. We included
physicians from HIV clinics in San Francisco, U.S.A. as well as from Copenhagen, Denmark. Physicians were
observed during their clinical work and subsequently interviewed with a semi-structured interview guide. Notes
on observations and transcribed interviews were analyzed with NVivo software.
Results: We enrolled 16 physicians from San Francisco and 18 from Copenhagen. When we discovered that
physicians and patients seldom discussed adherence issues in depth, we made adherence communication and its
barriers the focus of the study. The main patterns in physicians' communication with patients about adherence were
similar in both settings. An important barrier to in-depth adherence communication was that some physicians felt
it was awkward to explore the possibility of non-adherence if there were no objective signs of treatment failure,
because patients could feel "accused." To overcome this awkwardness, some physicians consciously tried to "de-
shame" patients regarding non-adherence. However, a recurring theme was that physicians often suspected non-
adherence even when patients did not admit to have missed any doses, and physicians had difficulties handling this
low believability of patient statements. We here develop a simple four-step, three-factor model of physicians'
adherence communication. The four steps are: deciding whether to ask about adherence or not, pre-questioning
preparations, phrasing the question, and responding to the patient's answer. The three factors/determinants are:
physicians' perceptions of adherence, awkwardness, and believability.
Conclusion: Communication difficulties were a main barrier in physicians' work with patients' adherence to HIV
medication. The proposed model of physicians' communication with patients about adherence – and the
identification of awkwardness and believability as key issues – may aid thinking on the subject for use in clinical
practice and future research.
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The prognosis of HIV-infected people has improved dra-
matically since the introduction of Highly Active Antiret-
roviral Therapy (HAART) [1,2]. However, a large
proportion of patients have poor adherence to HAART
[3,4], and this is the main reason for treatment failures
and the development of virological resistance [2,4,5]. Sev-
eral factors are related to non-adherence, especially
patient-related factors such as depression, abuse, and
weak social support, but also regimen complexity,
patient's lack of trust in the treatment, and poor patient-
physician relations [3,6,7]. When looking at physician
factors, we find that experienced physicians achieve better
patient adherence [8], and that trusting patient-physician
relations [9,10] and open communication [11] are associ-
ated with better adherence to HAART. In interviews,
patients also stress that communication with physicians is
important in maintaining adherence to HAART [12] as
well as other diseases [5,13]. Accordingly, guidelines for
treating patients with HAART recommend that adherence
be addressed at all follow-up visits to prevent treatment
failure [2,14]. The majority of physicians dealing with
HIV also report that they do so [15-18].
Physicians' communication with patients about adher-
ence to HAART can, however, be problematic. In descrip-
tive questionnaire and interview studies physicians have
identified lack of time and resources, as well as their own
lack of training as the main barriers to their communica-
tion with HIV-positive patients about adherence [16-18].
Furthermore, a recent systematic review has concluded
that two-way discussions and partnership in treatment
decisions regarding medicine-taking in general most
likely seldom take place [13]. To our knowledge, no
observational study exploring physicians' communication
with patients about adherence to HAART has been done
and no analytical model of adherence communication
has been developed.
The overall aim of this study was to observe and explore
physicians' work with patients' adherence. During the
study, communication emerged as a main issue. The aim
of the present analysis therefore is to describe, conceptu-
alize, and interpret the communication patterns of physi-
cians when they discuss with patients about treatment
adherence, and to explore the difficulties they face and the
ways they handle them. During this process we developed
a proposed model of four basic steps and three main fac-
tors/determinants of physicians' adherence communica-
tion. Since most HAART adherence studies have been
done in the U.S. [19], we wanted to explore the possible
role of contextual factors and included a U.S. setting as
well as a setting outside the U.S.
Methods
Qualitative research approach
We used interviews to explore how physicians understand
and make sense of their own situation and behavior [20],
and we used direct observation to transcend their own
understanding [21,22] in a multidisciplinary approach
based on medical qualitative research methods [23].
Inspired by comparative anthropology [21,24], we stud-
ied both US and European physicians to explore the role
of contextual factors.
We used a Grounded Theory methodology to interpret
our findings. Grounded Theory is a systematic method for
generating concepts from data and formulating relevant
hypotheses about the determinants and consequences of
the "Basic Social Processes" by which people handle their
main concerns [22,25]. The ultimate goal is to generate
theory or build a model that "works, fits, and is relevant,"
[22]. The model is modifiable and not a validated fact
[22,25]. In Grounded Theory, data are analyzed concur-
rently with data collection and the main issues are
allowed to emerge during coding and conceptualization
of data [22,25]. In Grounded Theory, the coding process
is divided into two or three stages. First, coding is "open"
and in the end it becomes "selective" [22,25]. Strauss and
Corbin furthermore describe an intermediate "axial" cod-
ing stage, where the concepts are organized into a "condi-
tional matrix" [25]. In this study, we used much of Strauss
and Corbin's practical advice for the analytic process,
while following Glaser's advice not to force the data into
a predefined "conditional matrix."
Prior to the interviews, we were familiar with the classical
health behavior models [26], some main adherence theo-
ries [27,28], the basics of physician-patient communica-
tion [29,30], and with guidelines for HAART adherence
counseling [2,31]. However, in Grounded Theory pre-for-
mulated concepts and theories are only used to "sensitize"
the researcher, as all concepts must earn their relevance
through constant comparison with data [22,25].
Settings and physicians
We chose San Francisco and Copenhagen, as both cities
may be expected to provide "state of the art" services. We
included five large outpatient clinics, three in San Fran-
cisco: University of California, San Francisco (UCSF), San
Francisco General Hospital (SFGH), Mission Neighbor-
hood Health Center (MNHC); and both of the two exist-
ing clinics in Copenhagen: Rigshospitalet (RH) and
Hvidovre Hospital (HH).
In San Francisco 16 out of 23 eligible physicians partici-
pated, in Copenhagen 18 out of 19. Of the seven non-par-
ticipants in San Francisco, three never responded to our e-
mail, three consented but were not included due to illnessPage 2 of 12
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tion. The non-participating physician in Copenhagen was
excluded because of time constraints. Table 1 shows the
characteristics of the participating physicians. An addi-
tional file includes calculated percentages of physicians
with each characteristic (Additional file 1).
Procedures and analysis
Data were collected from December 2001 to August 2003.
We invited all physicians employed at the clinics by e-mail
or posted letter and participants signed a consent form.
We gave patients an information sheet and all participat-
ing patients gave explicit verbal consent. The first author
observed each physician's consultations during one work-
day and simultaneously took notes on the physician's ver-
bal and some non-verbal communication. To minimize
intrusion and ensure confidentiality, and to facilitate par-
ticipation of all physicians, we did not tape-record or film
the consultations. Subsequently, a qualitative, semi-struc-
tured interview [20] with the physician was done about
how he or she had perceived and worked with patients'
adherence that day (interview guide enclosed as Addi-
tional file 2). Physicians were asked how they had
assessed and enhanced each patient's adherence, how
they would explain each patient's degree of adherence,
and how they recalled and interpreted their own commu-
nication with the patient about adherence. For validation,
physicians were invited to comment on the researcher's
noted observations and immediate interpretations, as rec-
ommended by Kvale [20]. These comments were included
as further data to verify, correct, and broaden the observa-
tions and interpretations of the researcher. Interviews
with physicians lasted about one hour, were audio-
recorded and transcribed verbatim. The handwritten
notes on observations were typed into a word-processing
program within one day of the interview.
At the end of interviews, physicians were asked if they felt
they had changed behavior due to the presence of the
observer. Generally, physicians stated that they were used
Table 1: Characteristics of participating physicians.
San Francisco (n = 16) Copenhagen (n = 18) Total (n = 34)
Gender
(female/male) 3/13 6/12 9/25
Age distribution
30–39 6 3 9
40–49 5 9 14
50–59 4 4 8
60–69 1 2 3
Specialty
Still in training 0 6 6
Infectious Diseases 4 12 16
Internal Medicine, incl. various specialties 9 0 9
Family Practice 3 0 3
Clinic affiliation
San Francisco: SFGH/UCSF/MNHC§ 10/3/3 - 10/3/3
Copenhagen: HH/RH§ - 7/11 7/11
Minutes per routine consultation
(mean and range) 25.5 (20 – 30) 16 (12 – 20) 20.5 (12 – 30)
Years of HIV ambulatory care
(mean and range) 10 (2 – 21) 9 (1 – 22) 9.5 (1 – 22)
Ethnicity
(Caucasian/other) 13/3 18/0 31/3
Working days per week in HIV ambulatory
(mean and range) 1.7 (1/2 – 4) 0.9 (1/2 – 1) 1.25 (1/2 – 4)
Eligible physicians not participating
(total number) 7 1 8
§San Francisco General Hospital/University of California, San Francisco/Mission Neighborhood Health Center; Hvidovre Hospital/Rigshospitalet.Page 3 of 12
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observer's behavior was easy-going and non-intrusive.
Fourteen of the physicians stated that there was no influ-
ence from the observer, 13 stated that they had been con-
scious of the presence of the observer, especially at the
beginning of the day, although it did not change their
adherence communication, and 6 said they had probably
focused a little more on adherence than they usually
would. One physician's answer to this question was not
recorded.
In the analysis, all interviews were replayed on audio and
all data were re-read several times. The transcribed inter-
views, as well as the notes on observations, were used as
data. First, a brief summary of the observations and inter-
view with each physician was written within one day of
the interview. Then, during open coding, all notes on
observations and the transcribed interviews were frag-
mented into meaning units (a few sentences or a para-
graph), which were labeled with one or more concepts or
statements. Concepts where developed both from the
interviewed physicians' own statements and the
researcher's interpretations. During the entire coding
process, analytical memos on concepts were written, con-
cepts were renamed, units of text were recoded, and recur-
ring themes were noted [22,25]. After the open coding, we
narrowed our focus to the communication process and
related concepts to each other during selective coding.
Theoretical relations between concepts (e.g., that XX leads
to YY) were developed from analysis of observations as
well as from interviews. During this process, several alter-
native models were developed and explored, and finally
we ended up with a simple four-stage three-factor model.
We did not arrive at a single core concept. For practical
handling of the large amounts of conceptualized text,
NVivo software was used (Version 2.0, by QSR Interna-
tional Pty).
We did the sampling at five different clinics in two differ-
ent cities to allow for the role of contextual factors to
emerge. However, as the similarities of communication
patterns at the different sites were much larger than the
differences, contextual factors came to play only a minor
role in the final analysis.
The first author, a bilingual physician with training in
qualitative research, did all the observations and inter-
views as well as the primary data analysis. Data collection
and analysis were continuously checked with the co-
authors (two physicians and one anthropologist) and
with external physicians and methodologists to validate
findings and broaden the analysis by incorporating view-
points from multiple disciplines [23]. The Institutional
Review Board at UCSF approved the study.
Patients and consultations observed
In total, 183 consultations were observed. In San Fran-
cisco, 49 consultations with patients receiving HAART
were observed as well as 11 consultations with patients
not currently on treatment. In Copenhagen, the corre-
sponding numbers were 95 and 28.
In San Francisco, we observed consultations with 42 men,
6 women and 1 transgender currently on HAART. In
Copenhagen, the corresponding numbers were 78, 17 and
0. In San Francisco, 27 were of Caucasian origin, 22 were
not. In Copenhagen, there were 77 and 18, respectively.
We aimed to minimize patient dropout and to allow an
undisturbed interaction between patient and physician.
Therefore we only collected the directly observable data
on patients, and did not ask about patients' age, mode of
transmission, housing situation or drug use habits.
However, we roughly estimate that in San Francisco 60%
of the included patients had been infected through homo-
sexual practices, 15% heterosexually, and 20% through
intravenous drug abuse, whereas the corresponding esti-
mates in Copenhagen are 50%, 40% and 5%, respectively
[3]. We further estimate that roughly 20% of included
patients in San Francisco were regular users of illegal drugs
other than marijuana and that 10% were homeless,
whereas the corresponding numbers in Copenhagen are
10% and <1%, respectively.
Approximately 10% of consultations were not observed,
as requested by patient or physician. Patients and physi-
cians most often explained that this was because sexual
issues were to be discussed. Only very few patients gave
other explanations or no explanation.
Results
Overview of findings and comparison of San Francisco and 
Copenhagen
The main communication patterns were similar in San
Francisco and Copenhagen. In both settings, in-depth dis-
cussions between patient and physician were rare,
although adherence was mentioned in more than half of
the consultations. Patients hardly ever brought up the
subject themselves and when physicians brought up the
subject, patients usually gave brief answers that often had
low believability. It emerged that physicians had individ-
ual communication patterns, which were not only deter-
mined by their perceptions about patients' adherence, but
also strongly influenced by their perceptions about the
awkwardness of discussing adherence with patients and
their perceptions about the believability of patients' state-
ments on adherence. These three aspects of physician per-
ceptions depended on the general attitudes of the
physicians as well as the specific circumstances with a spe-
cific patient (e.g., when a physician suspected that aPage 4 of 12
(page number not for citation purposes)
BMC Health Services Research 2006, 6:154 http://www.biomedcentral.com/1472-6963/6/154patient was non-adherent, it was a function of his or her
general suspicion of non-adherence as well as the observa-
tion of specific clues in this specific patient). The physi-
cians' age, gender, experience, and education did not
emerge as main determinants of their communication
with patients about adherence to HAART.
We here propose a model of how physicians' perceptions
of these three factors (adherence, awkwardness, and
believability) shaped their decision to ask about adher-
ence, their possible pre-questioning preparations, their
phrasing of the question, and their response to the
patient's answer. We present a simple outline of the
model (Figure 1) and an expanded version with subcate-
gories (Figure 2). The model is further explored in the
body of this paper. We first describe the three perception
factors and their main determinants (or "subcategories").
Then we describe the main ways that physicians act during
the four steps in the communication process and how the
three perception factors influence these actions. In turn,
we briefly look at the consequences of these actions for
the awkwardness, believability, and adherence informa-
tion content of patient responses as perceived by physi-
cian and researcher.
We observed a few differences between San Francisco and
Copenhagen in terms of adherence communication. Aver-
age consultations were longer in San Francisco than in
Copenhagen (26 vs. 16 minutes) (Table 1) and the subject
of adherence was mentioned in 36 of 49 (73%) consulta-
tions in San Francisco compared to 58 of 95 (61%) in
Copenhagen. Adherence discussions were slightly more
comprehensive in San Francisco, where a question style
implying that the patient had missed some doses of med-
ication was mainly observed, whereas a question style
implying good adherence was mainly observed in Copen-
hagen (described in more detail later). The atmosphere
seemed less formal in San Francisco than in Copenhagen,
e.g., some physicians gave patients a hug or told them
about incidents from the physicians' own private lives.
Since the similarities between communication patterns in
San Francisco and Copenhagen were so much larger than
the differences, in this paper we will not further dwell on
the differences.
Factor A: Adherence perceptions
Physicians' communication with patients about adher-
ence was – not surprisingly – strongly influenced by their
Model of physicians' adherence communication (simple version)Figure 1
Model of physicians' adherence communication (simple version). Physicians go through four steps when communicat-
ing with patients about adherence. The way physicians act in these is markedly influenced by three aspects of their perceptions 
(see figure 2 for an expanded version of the model).
These perceptions
influence physicians’
actions during four 
primal steps of 
adherence
communication
1: Deciding to ask
    about adherence
2: Pre-questioning 
preparations
4: Responding to 
patients’ answer
3: Phrasing
    the question
Physicians’
perceptions about: 
a) Degree and
    importance of
    adherence 
b) Awkwardness 
    of discussing
    adherence with
    patients 
c) Believability of
    patient statements 
    on adherence Page 5 of 12
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the perceived importance of adherence.
Physicians determined the degree of adherence both from
the treatment effect (viral load) as well as from situational
factors. If the patient had a rising viral load, physicians
would virtually uniformly be suspicious that the patient
might have low adherence, especially if the viral load was
rising from very low (i.e., "undetectable") levels. How-
ever, the interpretation of an undetectable (or otherwise
stable) viral load varied considerably, since some would
consider this proof that the patient was sufficiently adher-
ent, whereas others would still be very alert for poor
adherence. Physicians' interpretations of the patients' sit-
uational factors varied considerably. However, all physi-
cians generally made an overall assessment based on the
patient's lifestyle, abuse patterns, perceived personality,
and timing of medication refills, and they listened to
patients' statements regarding adherence.
Most physicians had the general perception that adher-
ence was very important: "It's the most important limiting
factor in treatment," (SF3) or "I do a lot, I think, around
adherence issues 'cause the stakes are so high" (SF11). A
few physicians, however, felt that there was no need to
worry much about adherence, as long as the viral load was
undetectable, and others did not worry if the patient
already had multi-drug resistance and a high viral load.
For example, one part of an interview went like this: "INT:
Can you say more about to what degree [patients] are suf-
ficiently adherent when they are undetectable? ... DR:
Well, I mean what is the goal of anti-viral therapy? I guess
it's to drive the virus to undetectable [...] INT: So you don't
think they could be missing enough to be at risk of devel-
oping resistance? DR: I don't care. That's not a big worry
to me – I'm not a big resistance-phobic person" (SF13).
Physicians who did not consider adherence to be an
important issue tended to communicate less with patients
on the subject.
Model of physicians' adherence communication (expanded version)Figure 2
Model of physicians' adherence communication (expanded version). Physicians go through four steps when commu-
nicating with patients about adherence. The way physicians act in these is markedly influenced by three aspects of their percep-
tions. Each of the four steps has its subcategories, and each of the three perceptions has its main determinants (see figure 1 for 
a simple version of the model).
These perceptions
influence physicians’
actions during four 
primal steps of 
adherence
communication
Broad & open
Suggestive
About
quality
If stated adherence is 
high and perceived 
believability is low,
three kinds of 
reactions are seen
If stated adherence 
and believability is 
high, physicians
briefly acknowledge
the answer
If stated 
adherence is 
low, physicians
explore
reasons and 
give advice and 
motivation
4: Responding to 
patients’ answer
Circum-
ventive
dialogue
Okaying
Con-
fronting
About
quantity
3: Phrasing
   the question
2: Pre-questioning 
preparations
“De-
shaming” Re: non-
adherence
Relationship
Ask
1: Deciding to ask
    about adherence Don’t ask
Physicians’ perceptions about: 
a) Adherence 
a. The degree of 
adherence (based on 
viral load and situational 
factors)
b. The importance of 
adherence (most find
adherence important) 
b) Awkwardness of discussing
adherence with patients,
which depends on: 
a. Previous visits
b. Signs of non-adherence
c. Other pressing issues
d. Relation with patient 
e. Focus on respect 
f. Communication style
g. Believability perceptions
c) Believability of patient 
statements on adherence: 
a. Specific evaluation
b. General perceptions
c. Interpretations of
reasons for low 
believabilityPage 6 of 12
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Physicians seldom spontaneously declared that exploring
adherence was an awkward thing to do. But when physi-
cians were asked in the interview why they had touched
on the subject the way they did, perhaps only superficially
or not at all, they often explained that further explorations
were unnecessary and also would have been too awkward:
"Some patients can get a bit offended if you ask [about
adherence]... They may feel that the trusting relationship
is challenged... I remember one patient who got very
defensive and said 'But you know that I have always taken the
medicine, why do you now suddenly start sitting there saying
things like that'." (Cph8).
Physicians mainly perceived explorations into adherence
to be too awkward if the patient had stated good adher-
ence on previous visits: "It's the awkwardness of the repe-
tition of the series of questions" (SF7). Physicians also
perceived explorations to be awkward when there were no
objective signs of non-adherence, when there were other
pressing issues in the consultation, or if the physician per-
ceived the relation with the particular patient to be diffi-
cult and fragile.
Explorations were also often considered awkward if the
physician generally focused very much on showing
patients respect and on avoiding creating feelings of guilt:
"I think [the physician] being in loco parentis too much is
not what adult [patients] are going to really be thrilled
about. You're more apt to get positive results if you're
trusting and a little lenient" (SF13), or "I'll rather praise
people than make them feel guilty by insisting on explor-
ing something that may not be working ideally, but which
works okay" (Cph15).
Exploring adherence was not perceived as awkward if the
physician had a "de-shaming" communication style (see
below), did not worry about the patients' possible feelings
of shame and the believability of the answer, or did not
perceive the patient relation to need special nurturing.
Factor C: Believability perceptions
Believability issues were also important during all four
steps of physicians' communication strategies and were
determined by the specific situation as well as the physi-
cian's general perceptions.
In the specific situation, the believability of a patient's
claims of good adherence was evaluated by physicians
from their independent assessment of the patient's degree
of adherence (based on viral load and situational factors
as described above), coupled with the patient's perceived
general trustworthiness and the phrasing and tone of the
patient's adherence statements. If the patient was very
firm in his intonation or detailed in his description of
medication intake, the patient's answer would more often
be believed. If patients disclosed non-adherence, physi-
cians practically always believed this, although they some-
times felt the non-adherence was understated.
Physicians differed in their general perceptions regarding
believability. Some physicians felt that patient statements
on adherence were generally believable: "I actually believe
what patients tell me" (Cph1), and physicians could even
seem torn between their suspicion of poor adherence and
an almost moral obligation to trust patients. Others
accepted low believability with ease: "It's ... in my opin-
ion, one of the hardest things to get a truthful answer for
(SF9).
The underlying reasons for low believability were
explained by physicians in various ways. Quite often, low
believability was explained by the patient's politeness or
sympathy with the doctor: "Clients are very aware of what
their doctors want to hear, particularly if they like their
doctor" (SF9), or by the patient's shame: " [Admitting
having missed doses] is an admission of failure. And then
they think the doctor finds them stupid or not serious
about it" (Cph13). Low believability of patients' answers
was seldom attributed to poor memory or mental repres-
sion, though sometimes to "craziness" or unacceptable
manipulation and arrogance: "I just don't want to sit there
and be ridiculed ... that they just sit and decide they know
better than me" (Cph14).
In the following, we will explore how physicians' percep-
tions of adherence, awkwardness, and believability influ-
ence the way physicians handle the four steps in the
communication process.
Step 1: Deciding whether to ask about adherence or not
Some physicians rarely asked about adherence, others
asked only superficially, and very few asked most of their
patients in depth. Physicians' decision to ask or not was
largely determined by their perceptions of adherence,
awkwardness, and believability. Patients hardly ever
brought up the subject themselves.
Generally, physicians usually asked about adherence if
they perceived a patient's adherence to be low and they
perceived adherence to be an important issue.
However, if physicians perceived the specific patient's
adherence to be good, or if they generally did not consider
it a very important issue, they often felt that it was not nec-
essary to ask, and also that it would have been awkward to
do so: "The reason that I do not ask more [... about adher-
ence] could be that it feels unnecessary. And it could per-
haps seem like a silly question, sometimes" (Cph1).Page 7 of 12
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they had very low trust in the believability of patients'
answers on this issue: "To ask 'Do you sometimes forget to
take your medication' can be used for nothing ... There are
these studies we have seen, showing it is useless. It's fifty-
fifty whether they answer yes or no – no matter what situ-
ation they have been in" (Cph7).
On the other hand, physicians could also be led to abstain
from asking about adherence if they trusted the patients
so much that they even expected them to spontaneously
tell about possible adherence problems: "I will not ask ...
everybody whether they have ... forgotten a dose on a sin-
gle occasion ... this of course has to do with that I gener-
ally believe ... patients' bring up their problems to surface"
(Cph1).
Step 2: Pre-questioning preparations
Physicians were asked if they did anything to facilitate
communication about adherence. Most answered that
they – even before asking about adherence – tried to create
a trusting, informal, and friendly atmosphere. Physicians
often felt this "de-shamed" patients and made it easier for
patients to be honest, e.g., about non-adherence. Many
physicians were also observed to have an informal body
language, to use slang and jokes, and to chat with patients
about private things, like how the patient had spent his
vacation.
Physicians usually popped adherence questions abruptly
without warning. Only when physicians were very aware
of awkwardness and the need to promote believability did
they prepare patients for the question with a "warning
shot," e.g. by referring to prior discussions or the results of
recent blood tests. One physician was also observed to
"de-shame" a patient by generalizing adherence problems
prior to asking about adherence, saying: "Most people
find it hard to remember taking the medication" (Cph8).
This remark did trigger disclosure of non-adherence and
other physicians referred to prior successful use of similar
phrases.
Step 3: Phrasing the question
When physicians individualized questions and picked
from a broad palette of question styles and content it
seemed to facilitate elaborate answers. However, most
physicians used a favorite phrase with most patients.
Question styles
Broad and open questions were common. Physicians asked,
"How are you doing with the medication?" (SF11) or
"How is it going with taking the medication?" (SF15).
Patients' first answers were often only superficial or not
about adherence. Only when physicians gave very much
priority to adherence, would they follow-up with ques-
tions that were more specific.
Suggestive questions were also common. Suggestive ques-
tions implying that some doses might have been missed
could be, "How many doses have you missed in the last
14 days" (SF14). Such questions were mainly asked when
physicians were very focused on the need to promote
believability. Physicians felt such phrasing made it less
awkward for people to admit having missed doses,
because "this means everybody is missing" (SF14). On the
other hand, suggestive questions implying good adher-
ence could be, "You don't have any problems taking your
medication, do you?" (Cph11). This kind of phrasing was
mainly used when physicians were less focused on the
need to promote believability and more focused on main-
taining a respectful, non-awkward communication in
general. Such phrases seemed to function mainly as a
reminder to the patient of the importance of adherence
and less as a facilitator of in-depth dialogue on the sub-
ject.
The tone of questions was mentioned by a few physicians
who focused a lot on believability: "I always ask to what
degree they're taking their pills and I try to do it in a low-
key manner – kind of like offhand – so that my patients
have an absolute sense that they can tell me everything"
(SF1).
Content of questions
Questions about the quantity of missed doses were common
when physicians perceived adherence to be important.
These questions were used both to assess adherence and
to remind the patient of its importance. Different degrees
of specificity in number and time range were addressed,
though a time range of two weeks was often used. Answers
to these questions were often vague and their believability
was often not convincing both to the physician and the
observer.
Questions about the qualitative adherence-related aspects of
medication intake were mainly asked when adherence was
perceived to be an important but potentially awkward
issue. These seemed less awkward to ask than questions
about the quantity, and the answers seemed more believ-
able. Three main topics were addressed:
* Knowledge of the regime: Whether patients could
describe their regime was routinely checked by some: "I
want to know what they are really taking, because... so
many times they are not taking what is [written] on the
bottle" (SF7).
* Motivation for treatment and adherence: This was
mainly asked about by checking for side effects, whichPage 8 of 12
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to treatment. The patients' perception of positive treat-
ment effects or their motivation for adherence was very
seldom asked about.
* Behavioral patterns. Only when physicians gave adher-
ence very high priority and they were very aware of the
awkwardness of the subject did they ask about the rou-
tines patients had or could develop for taking and remem-
bering the medication, and how they handled difficult
adherence situations. Patients did, however, seem to talk
more freely about these practical problems with adher-
ence and seemed to become aware of new solutions.
Step 4: Responding to patients' answers – handling varying 
degrees of believability
Responses to patients stating good adherence with high believability
When physicians perceived the believability of a state-
ment on good adherence to be high, they would usually
briefly acknowledge the answer, perhaps with praise, a
warning about the possible consequences of non-adher-
ence, or a question about side effects. Many physicians felt
that a further exploration of the patient's adherence strat-
egies would be awkward and unnecessary in this situa-
tion.
Responses to patients stating good adherence with low believability
Physicians responded to patients' statements of good
adherence with low believability in three ways: Okaying,
circumventive dialoguing, and confronting.
Okaying the answer despite its low believability was mainly
done when physicians thought adherence was not that
important, or that further explorations would be awk-
ward, mainly because the relation to the patient was frag-
ile. One physician more generally okayed patient
statements even when they had low believability: "It was
the message I wanted to send – that they can answer me
whatever they want" (Cph15).
Circumventive dialoguing is here defined as continuing the
communication on adherence without drawing attention
to the possible low believability of patient statements.
One important way to do circumventive dialoguing was
to address the qualitative adherence-related aspects of
medication intake instead of the quantity of missed doses,
e.g., by asking what time of the day the medicine was
taken, whether it was taken with food, etc. Another kind
of circumventive dialogue was to re-ask closed questions
about occurrence of missed doses, but with altered specif-
icity regarding the time frame or number of missed doses.
This was several times observed to elicit otherwise hidden
non-adherence. For example, one dialogue went like this
(SF2):
"Any problems with the medicine?"
"No."
"You take them all?"
"Yes, the 3TC, the Viramune... and the eeh, Epivir."
"Any problems taking them?"
"No."
"You took them this morning?"
"No man! I did not take them this morning!"
Confronting low believability covers a range of reactions
from subtle signals of doubt to clear expressions of anger.
For example, physicians confronted patients without
being aggressive by stating that the patient's rising viral
load without mutations was most easily explained by low
adherence. Sometimes physicians explicitly asked for
honesty. When physicians perceived low believability as
unacceptable they were sometimes observed to shame the
patient for lying or to get upset and angry, i.e., they dis-
played a raised voice and flushing skin.
Responses to patients stating poor adherence
Physicians virtually always believed in statements of poor
adherence. Physicians explored the underlying reasons for
poor adherence and attempted to assist with behavioral
advice or they tried to strengthen motivation for adher-
ence through information, condemnation, or shaming of
the patient.
Discussion
We found that physicians' communication with patients
about adherence was often awkward and superficial, even
when physicians tried to create a friendly atmosphere. To
"de-shame" patients regarding poor adherence was an
important, but underused strategy for facilitating commu-
nication on the subject. Physicians' interpretation of the
believability of patients' statements on adherence was
another major factor in the communication process. We
developed a simple four-step model of physicians' com-
munication with patients about adherence, where the
content of each step depends on the physician's percep-
tion of three things: adherence, awkwardness, and believ-
ability. The main communication patterns were similar in
San Francisco and Copenhagen, although a question style
implying poor adherence was mainly observed in San
Francisco and the adherence discussions in San Francisco
were slightly more comprehensive than in Copenhagen.Page 9 of 12
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provide a model of physicians' communication with
patients about adherence to HAART and the first study to
propose a conceptualization of its main determinants.
The main weaknesses of this kind of study are that the
analytical model cannot be interpreted as validated fact
[20,22,23] and that the descriptive aspects cannot be gen-
eralized to other settings. San Francisco and Copenhagen
are not typical HIV treatment sites, e.g., because of their
high research priorities. However, the conceptual prod-
ucts of Grounded Theory methodology should have good
a "fit" within context and can also sensitize physicians and
researchers in other settings to the basic social processes
discovered, although the specified processes may be less
prevalent elsewhere [22]. Thus, the findings may be rele-
vant in non-HIV settings as well.
It is a possible source of bias that the observation itself
may have made physicians focus more than usual on
adherence, despite their explicit statements to the contrary
[32], and may have made the consultations more awk-
ward. However, even though observations only lasted half
a day to one day, there were very few indicators that the
observed consultations were not "typical." Another limi-
tation is the non-inclusion of patient's viewpoints,
although our findings are supported by others who have
interviewed patients [33-40].
Even in the expanded outline of the model with subcate-
gories (Figure 2), we have not included the connections
between specific perceptions and specific behaviors, as it
would make the figure overly complex. This complexity of
the full analysis may be viewed as a weakness of the study.
However, but we believe the simple model (Figure 1) con-
veys the main messages.
The aforementioned minor differences in communication
patterns between physicians in San Francisco and Copen-
hagen may be tentatively explained by some differences in
context. As compared to Copenhagen, the clinics in San
Francisco had longer consultations, much less follow-up
by nurses, and a patient population with more homeless-
ness and drug abuse. San Francisco, moreover, tradition-
ally has a strong gay grass-roots HIV movement and a
political HIV commitment among physicians, possibly
linking physicians there very close to their patients. There
may also be a general American tendency to openly shar-
ing feelings [41]. Furthermore, some eligible physicians in
San Francisco did not participate, leaving a selected sam-
ple to be studied. All this may contribute to the slightly
more comprehensive adherence discussions and more
consciously developed communication strategies
observed in San Francisco than in Copenhagen.
Previous interview studies have highlighted lack of time,
resources, education, and experience as the barriers to
physicians' work with patients about adherence to HAART
[15-18]. Our study highlights communication and the
crucial role of adherence perceptions, awkwardness, and
believability. These aspects of social interaction are often
not given much attention in standard theories about
health behavior [26], patient communication [29], and
adherence support [2,14].
Recent studies find that HIV+ patients seldom tell physi-
cians about adherence problems [34,35,42]. Our study
points out physicians' difficulties of doing interviewing
and counseling when patients are reluctant to tell about
their problems. This is supported by a study of hyperten-
sion that points to the role of physicians' question styles
in receiving believable information on adherence [43].
Our findings are also in line with an interesting study,
which finds that when general practitioners meet a non-
adherent diabetes patients, they tend to get frustrated and
adopt a paternalistic attitude, and try to threaten and pres-
surize patients into becoming adherent [44].
The existing theory of motivational interviewing holds
that assistance in behavior change should not primarily
be done by giving advice and information, but rather by
assisting patients in exploring their own priorities and in
developing their own strategies for solving problems [30].
In line with this, recent guidelines for counseling about
adherence to HAART [14] and other medications [5] stress
that physicians should develop a partnership with
patients and communicate in a non-judgmental way.
These recommendations for clinical practice are sup-
ported by our findings. However, we suggest they be sup-
plemented with an enhanced focus on "de-shaming"
techniques, the provision of a broadened palette of ques-
tion styles, and some conscious strategies for sensibly
handling low believability of patient statements on adher-
ence. We believe this would make physicians better
equipped for supporting patients' adherence.
Future research needs to challenge or verify our findings in
other settings. Patients' perceptions of the awkwardness of
discussing adherence and the background for low believ-
ability also need to be further explored.
Conclusion
We found communication to be a main difficulty in phy-
sicians' work with patients' adherence to HAART. We
developed a simple model of adherence communication,
identifying three factors that influence how communica-
tion may proceed through four steps. This model – and
the identification of awkwardness and believability as key
issues in patient-physician communication on this subjectPage 10 of 12
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tion for use in clinical practice and future research.
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